Buprenorphine Treatment Centers in Kentucky

Kentucky recorded 2,077 drug overdose deaths in 2023 — a 48.0-per-100,000 age-adjusted rate that placed the state among the top ten for mortality. Kentucky was an early adopter of statewide MAT expansion, and it now operates a robust network of Office-Based Opioid Treatment (OBOT) providers alongside its 22 SAMHSA-certified OTPs. NWVCIL's directory tracks 245 buprenorphine providers in Kentucky, with 24 in Lexington, 24 in Louisville, and 13 in Elizabethtown — a notably even distribution across the state's two largest metros plus a third concentration along the I-65 corridor. Kentucky Medicaid covers MAT without prior authorization and reimburses for peer-support services delivered alongside medication — a benefit that increases retention in early recovery. 385 of the 437 verified facilities in our directory accept Medicaid, and 386 offer telehealth (88%), both above-median figures nationally. The Kentucky Office of Drug Control Policy coordinates statewide opioid-response funding and supports navigation services. For a Kentuckian starting buprenorphine, common pathways include: a private MAT clinic in Lexington or Louisville for insured patients, a Comprehensive Care Center in one of the state's 14 regions, a Federally Qualified Health Center for Medicaid and uninsured patients, or a telehealth visit with a Kentucky-licensed prescriber. Most providers can prescribe Suboxone, Subutex, Zubsolv, or the long-acting Sublocade injection. The KY HELP Statewide Call Center (1-833-859-4357), SAMHSA's national helpline (1-800-662-4357), and the 988 Suicide and Crisis Lifeline are available 24/7.